Aditya Mohanty | executive |
Eric d'Esparbes | executive |
Joseph Pantginis | analyst |
Rei Tan | analyst |
John Vandermosten | analyst |
Greetings, and welcome to Biora Therapeutics First Quarter 2024 Financial Results Call.
As a remainder, this conference is being recorded.
I will now turn the call over to Chuck Padala, Managing Director with LifeSci Advisors, Biora's Investor Relations firm. Please go ahead.
Thank you, operator.